 | Psilocybin: Encyclopedia II - Psilocybin - Effects
Psilocybin - Effects
Psilocybin is absorbed through the lining of the mouth and stomach. Effects begin 20-45 minutes after ingestion of psilocybin-containing mushrooms, and last from 2-6 hours depending on dose, species, and individual metabolism. If mushrooms are chewed and held in the mouth, or taken as mushroom tea, effects begin slightly sooner and are usually noticeable within 15 minutes. This is typically done in combination with Orange juice or another drink with power taste to dilute the unpleasant taste of Psilocybe mushrooms. Nausea is not uncommon when ingesting Psilocybe mushrooms, but typically subsides within an hour of appearing or less. Sometimes vomiting will occur. Some users have also been known to induce vomiting after psilocybin begins to take effect as the drug is already in the system and this will relieve the nausea which can be mild to very unpleasant.
At low doses, hallucinatory effects occur, including walls that seem to breathe, a vivid enhancement of colors and the animation of organic shapes. At higher doses, experiences tend to be less social and more entheogenic, often catalyzing intense spiritual experiences. For example, in the Marsh Chapel Experiment, which was run by a graduate student at Harvard Divinity School under the supervision of Timothy Leary, graduate degree divinity student volunteers who received psilocybin, almost all reported profound religious experiences. (A brief video about the Marsh Chapel experiment can be viewed here.) In fact, some people who have eaten the mushrooms without knowing of their hallucinatory effects typically believe they have had an unprovoked religious experience.
The effects are often pleasant, even ecstatic, including a deep sense of connection to others, and a general feeling of connection to nature and the universe. However, as with all psychedelic chemicals, not all experiences are positive. This is especially true when they are taken with other drugs, during times of mental instability, or by people with psychoemotional problems. In such situations, "bad trips" are much more likely to occur. Anxiety, frightening hallucinations, confronting (symbolically or literally) past or deep-seated internal conflicts, and feelings of permanent disconnection from reality and the Self can be quite intense and cause panic. The possibility of such experiences may be mitigated by being cognizant of one's set and setting.
A non-physiologically induced dreaminess is present up to 24 hours following administration, presumably representing the need to reflect and integrate the content of a profound hallucinogenic experience well into the next day.
A very small number of people are unusually sensitive to psilocybin's effects, where doses as little as 0.25 grams of dried Psilocybe cubensis mushrooms (normally a threshold dose of around 2 mg psilocybin) can result in effects usually associated with medium and high doses. Likewise, there are some people who require relatively high doses of psilocybin to gain low-dose effects. Individual brain chemistry and metabolism plays a large role in determining a person's response to psilocybin.
Psilocybin is probably metabolized mostly in the liver where it becomes Psilocin, but is also broken down by the enzyme monoamine oxidase. MAO inhibitors have been known to sustain the effects of Psilocybin for longer periods of time; people who are taking an MAOI for a medical condition (or are seeking to potentiate the mushroom experience) should be careful.
Mental and physical tolerance to psilocybin builds and dissipates quickly. Taking psilocybin more than three or four times in a week (especially two days in a row) can result in diminished effects. Tolerance dissipates after a few days, so frequent users often keep doses spaced five to seven days apart to avoid the effect.
Other related archives1977, 2002, 2004, 2005, Albert Hofmann, Amanita muscaria, Amsterdam, Bill Hicks, British Virgin Islands, California, Central Intelligence Agency, Class A, Convention on Psychotropic Substances, DEA Schedule 1, Denmark, Finch, Georgia, Harvard Divinity School, Idaho, Incubus, January 18, Japan, LD50, LSD, Lewis Black, Liberty cap, MAO inhibitors, MDMA, Marsh Chapel Experiment, Multidisciplinary Association for Psychedelic Studies, Netherlands, Norway, Psilocybe, Psilocybe cubensis, Psilocybe semilanceata, R. Gordon Wasson, Spores, Super Troopers, Terence McKenna, Timothy Leary, United Kingdom, United States, University of Delaware, World Cup, acidic, agonist, alkaloid, ascorbic acid, bad trips, baeocystin, caffeine, cannabis, chemical reaction, citric acid, cluster headaches, dephosphorylation, entheogenic, enzymatically, ethanol, fungi, hallucinations, liver, magic mushrooms, methanol, methyl, monoamine oxidase, mushrooms, mycelium, norbaeocystin, organic solvents, pharmacologically, phosphatases, prodrug, psilocin, psychedelic, psychopharmacology, rats, serotonin, set and setting, tryptamine, zwitterionic
 Adapted from the Wikipedia article "Effects", under the G.N U Free Docmentation License. Please also see http://en.wikipedia.org/wiki |